ARTA
PRQR icon

A.R.T. Advisors’s ProQR Therapeutics PRQR Stock Holding History

A.R.T. Advisors’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-28,202
Closed -$244K – 1596
2015
Q4 		$244K Buy
28,202
+13,841
+96% +$159K 0.01% 1138
2015
Q3 		$209K Buy
+14,361
New +$240K 0.01% 1156
2015
Q2 		– Sell
-9,404
Closed -$205K – 1665
2015
Q1 		$205K Buy
+9,404
New +$194K 0.01% 1223

Other funds holding PRQR

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM

A.R.T. Advisors's PRQR Position: Q1 2016 in Review

A.R.T. Advisors sold out of ProQR Therapeutics (PRQR) in Q1 2016, closing a stake of 28,202 shares — an estimated $244K sold.

A.R.T. Advisors first reported a position in PRQR in Q1 2015 and held it in 3 quarters. The position peaked at $244K in Q4 2015. 29 funds tracked by Wall St. Rank hold PRQR as of Q1 2016.

  • A.R.T. Advisors reported no remaining ProQR Therapeutics position as of Q1 2016 after selling out during the quarter.
  • A.R.T. Advisors sold 28,202 ProQR Therapeutics shares in Q1 2016, an estimated $244K.
  • A.R.T. Advisors first reported a position in ProQR Therapeutics in Q1 2015 and held it in 3 quarters.
  • A.R.T. Advisors's ProQR Therapeutics position peaked at $244K in Q4 2015.
  • 29 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q1 2016.

Based on A.R.T. Advisors's 13F filing for Q1 2016, filed 16 May 2016.